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Background: The therapy of retained fetal membranes (RFM) is a controversial subject. In Swit-
zerland, intrauterine antibiotics are routinely administered although their effect on fertility pa-
rameters is questionable. The objective of this study was to compare the post-partal period after a 
routine treatment of RFM in 2 groups: one group received a placebo additionally (A), whereas the 
other group received a phytotherapeutic substance (lime bark) (B) additionally. The routine 
treatment of RFM included an attempt to manually remove the fetal membranes (for a maximum 
of 5 min), intramuscular administration of oxytetracycline and intrauterine treatment with tetra-
cycline. In case of an elevated rectal temperature (>39.0˚C), an additional non-steroidal inflam-
matory drug was allowed. Methods: Cows undergoing caesarean section, suffering from prolapse 
of the uterus, deep cervical or vaginal injuries, hypocalcaemia, and illnesses during the last 14 
days before calving were excluded. Cows had to be more than 265 days pregnant. Only cows that 
were artificially inseminated after RFM were included. Group stratification was done according to 
the last number on the ear tag (even/uneven) with (n = 50) cows in group A and (n = 55) cows in 
group B. Results: The number of treatments after the initial treatment of RFM was not significantly 
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in group A compared to 82 days in group B (p = 0.72). The number of AI’s until conception was not 
significantly different between groups. The median number of days open was 89 days in group A 
compared to 96 days in group B (p = 0.57). The culling rate was not significantly different between 
groups. Conclusion: There was neither a difference between the groups concerning therapies 
within the first 50 days after RFM nor concerning the subsequent fertility variables. 
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The incidence of retained fetal membranes (RFM) ranges from 4% to 11% of all calvings in a herd [1] with fail-
ure to expulse the fetal membranes within 12 to 24 hours after calving [2]-[4]. Following RFM, the uterus be-
comes contaminated with bacteria [5]. This has a negative impact on reproductive performance in cattle [5] in-
cluding delayed uterine involution, a prolonged interval to first service [6] [7], an increased number of services 
per conception [8], a decreased conception rate [9] and a prolonged interval of days open [5]-[7]. Furthermore, 
mastitis, ketosis and milk production losses may occur [10]-[12]. A meta-analysis of different studies showed 
that RFM is associated with 2 to 3 more days to first service; the conception rate at the first service following 
RFM is 4% - 10% lower, resulting in a 6 - 12 day prolonged interval to conception [3]. One study even showed 
a 22% lower conception rate at first service, resulting in a 29 day longer service interval [13]. There are many 
risk factors known for RFM [5], such as induced parturition [14], shortened gestation length [15], abortion [16], 
twinning [13] [17], dystocia [14] [18], caesarean section [14], nutritional deficiencies (selenium, vitamin E, and 
carotene) [19] [20], infectious agents such as BVD-virus [21], and immune-suppression [22]. It has been esti-
mated that cows suffering from RFM and clinical metritis produce 300 - 500 kg less milk compared with unaf-
fected herd mates, based on a 305 day corrected milk yield [23]. The UK dairy industry loses approximately 16 
million pounds a year due to cows affected by metritis/endometritis following RFM [24]. 
The treatment of RFM is a controversial subject [2]. Bolinder and coworkers (1988) showed that 100% of the 
cows at 3 weeks postpartum and 37% of the cows at 5 weeks postpartum showed pathogenic bacteria in the ute-
rus after the manual removal of the placenta compared to 37% and 12% respectively, in cows without manual 
removal [25]. Drillich et al. demonstrated that 84.3% of the cows after manual removal of the placenta devel-
oped fever [26]. Furthermore, remnants of cotyledons were found on caruncles, and hemorrhages and thrombi 
could be seen microscopically in cows after assumed removal of RFM [4]. Nevertheless, the manual removal of 
RFM together with the administration of tetracycline boli is still the routine treatment in Switzerland [27], as 
well as in other countries [5]. Different studies recommended the use of tetracycline boli due to its broad anti-
bacterial spectrum and its ability to retain its antibacterial properties in the presence of organic material 
[28]-[30]. However, the administration of intrauterine antibiotics did not reduce the incidence of metritis fol-
lowing RFM and could not improve fertility parameters [23]. Switzerland has a long history of using phyto-
therapeutic drugs in veterinary medicine [31]. The “Reinigungstrank Natürlich” (RN, Fritz Suhner Rena Handels 
AG, Hindelbank, Switzerland) used in this study was first produced in 1937 (Suhner, personal communication). 
The RN consists of lime bark (tilia cordata/tilia platyphyllos). The production of RN is man-made by Fritz 
Suhner III and his wife: the cambium and the cortex need to be separated from the rest of the trunk. The bark 
then gets stored to dry for six months, before grinding it to powder (Suhner, personal communication). The drug 
was registered in 1940 (Swissmedic registration-number 10’175) as one of the first phytotherapeutic substances 
ever [32]. Different studies described the ingredients of lime bark. The tanning agents are ellagic acid, gallitan-
nine, gallic acid, and protocatechuic acid. Different organic acids were found in lime bark like: aesculin, fraxetin- 
8-beta-glucopyranosid, resin acid and linoleic [33] [34]. Lime bark has been used throughout history to treat 
gunshot wounds, eye inflammations, burns and ulcerations [33]. It can be given to cows with concentrates or 
brewed up as a “tea”. There are more than 1000 farms all over Switzerland using RN (Suhner, personal commu-
nication). RN is used to stimulate the discharge of lochia resulting in improved fertility parameters (CliniPharm, 
Swissmedic 10175). Until now, there is no scientific literature available about the efficacy of RN. Therefore, the 
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objective of this study was to compare a routine treatment of RFM in 2 groups: one group received RN addi-
tionally, whereas the other group received a placebo additionally. Our hypothesis was that the days open in the 
RN-group would be 5% shorter than in the placebo group and secondly that number of gynaecological treat-
ments during the first 50 days after parturition would decrease in the RN group. If so, routine treatment could be 
replaced by RN exclusively in a follow-up study. 
2. Material and Methods 
2.1. Animals, Including and Excluding Criteria 
The study was conducted on dairy farms in different parts of Switzerland. Multiparous Brown Swiss cows and 
their crossbreeds suffering from RFM were included. The farms were free stall facilities or tie stalls and all the 
cows had access to pasture. 
Cows undergoing caesarean section, suffering from prolapse of the uterus, deep cervical or vaginal injuries, 
hypocalcaemia, and illnesses during the last 14 days before calving were excluded. Cows had to be more than 
265 days pregnant, and only one cow per day and per farm was included to prevent cluster effects. Only cows 
that were artificially inseminated after RFM were included. 
2.2. Study Design and Treatment 
A total of five veterinary practices were involved in the study, lasting from September 2012 to March 2014. 
These practices mainly treated cows with seasonal calvings (beginning of September to end of January). The 
standard therapy for a cow with RFM was: recording the rectal temperature, an attempt to manually remove the 
placenta (maximal time 5 min), systemic administration of oxytetracycline intramuscularly (i.m.) (10 mg/kg of 
body weight SID Engemycin 10%, MSD Animal Health GmbH, Luzern, Switzerland) and intrauterine treat-
ment with tetracycline (2 boles with 2 g each, Tetran forte, Dr E. Graeub AG, Bern, Switzerland). In case of an 
increased rectal temperature (>39.0), an additional non-steroidal anti-inflammatory drug was allowed. A rectal 
examination of the uterus was optional. All first treatments were performed by a veterinarian between 8 and 96 
hours postpartum. Cows were randomly assigned to routine treatment and placebo for ten days (A, even ear tag) 
or routine treatment and RN (B, uneven ear tag) for ten days. The placebo consisted of dry, ground apples (pro-
duced by Häflinger mill in Gipf/Oberfrick, Switzerland). The RN consists of lime bark (tilia cordata/tilia platy-
phyllos). The placebo and RN were delivered in neutral packages of 400 g (marked with “A” or “B”) and it was 
not possible to tell the ingredients apart. The placebo or RN was fed by the farmer. The daily dose was 40 g us-
ing a standard cup and the substances were given for 10 days together with concentrate. 
The veterinarian had to fill out a questionnaire (identification of the cow, state of the placenta, rectal body 
temperature, treatment group, additional treatment). Part of this questionnaire was left on the farm. Further 
treatments and gynaecological examinations, dates of inseminations and pregnancy examination had to be 
documented by the farmer. Once pregnancy was confirmed or at the latest when the cow was calving again, the 
questionnaire was collected by the author and the data transferred to an Excel sheet. 
2.3. Variables Evaluated 
Pregnancy duration and calving assistance were recorded. Calving assistance was categorized as 0 = none, 1 = 
light, 2 = medium (1 man), 3 = strong (2 men), 4 = veterinary assistance. The primary endpoint compared be-
tween the groups was “days open”. Further variables were also recorded: the interval from calving to first in-
semination, number of AI’s until conception, subsequent treatment of uterus (local administration of antibiotics 
or disinfectants); the reasons for culling during the lactation following RFM. 
2.4. Statistics 
Metric data are described with median and quartiles. This data from both groups are compared with the Mann- 
Whitney test for independent groups. Categorical data are described with percentages of the categories. This 
data from both groups are compared with the chi-squares test or Fisher’s exact test, deriving the p-values by ex-
act calculations if necessary. 




3.1. Animals and Farms 
A total of n = 50 cows in group A and n = 55 cows in group B were included. The descriptive measures for the 
following parameters: age of cows (years), number of cows/farm, yearly milk yield/cow (kg), duration of preg-
nancy, treatment at hours p.p., interval from calving to first insemination, number of AI’s, and days open for 
both groups are listed in Table 1. There was no significant difference found between the groups for all parame-
ters listed. The type of stall was either a free stall (A/B: n = 26/n = 18) or a tie stall (A/B: n = 19/n = 33), a sig-
nificant difference was calculated (p = 0.03). 
3.2. Calving/Placenta 
Calving assistance is listed in Table 2. There were no significant differences between the groups (p = 0.69). In 
each group, n = 2 cows had been suffering from retained placenta after the previous calving (p = 0.92). Degree 
of placental retention and removability is also listed in Table 2. 
 
Table 1. Median values (25%/75%) and p-values of the groups placebo (A) versus RN (B). There were no significant dif-
ferences between the groups. 
Parameters Group A Group B p-value (2-sided) 
Age of cows (years) 5 (3/6) 4 (3/5) 0.162 
Number of cows/farm 19 (14/30) 20 (15/28) 0.895 
Yearly milk yield/cow (kg) 6800 (6500/7000) 6500 (6300/7000) 0.181 
Duration of pregnancy (days) 290.5 (286/295) 291 (283/294) 0.344 
Treatment p.p. (hours) 20 (12/24) 18 (12/24) 0.862 
Calving to 1st insemin. (days) 77 (58/104.5) 82 (66.5/96) 0.722 
Number of AI’s 1 (1/2) 1 (1/2) 0.588 
Days open 89 (65/128) 96 (71/120) 0.566 
 
Table 2. Number of cows and p-values of the groups placebo (A) versus RN (B). There were no significant differences be-
tween the groups as to calving aid, placenta and additional first therapy. 
Parameters Group A Group B p-value (2-sided) 
Calving aid   0.69 
unassisted 28 31  
light 11 12  
1 man 8 5  
2 men 1 2  
veterinarian 2 5  
Placenta   0.60 
fully retained 24 32  
partially retained 26 23  
easily removable 22 26  
not removable 28 29  
Additional 1st therapy   0.60 
steroids 7 5  
NSAIDS 8 11  
oxytocin 3 7  




There were 12 cows in group A with an elevated body temperature at first therapy compared to 11 cows in 
group B (p = 0.62). All cows received oxytetracycline i.m. and intrauterine treatment with tetracycline boles. 
Additional first therapies are listed in Table 2. The second therapy was performed 2 days after calving (median; 
2/4 days = 0.25/0.75 quartiles) in group A; 3 days (median; 2/3.5 days = 0.25/0.75 quartiles) in group B. Again, 
cows received tetracycline boles (A/B: n = 28/n = 29), oxytetracycline i.m. (A/B: n = 12/n = 21); anti-inflam- 
matory drugs (A/B: n = 4/n = 6); differences between the groups were not significant (p = 0.052). There was no 
significant difference (p = 0.33) between the groups as to number of treatments concerning the uterus (irrigation, 
PGE2, PGF2α) within the first 50 days after calving (A/B: n = 14/n = 11). 
3.4. Fertility Variables 
The interval between calving and first insemination was 77 days (median; 0.25/.75 quartiles: 58/104.5 days) in 
group A compared to 82 days (66.5/96 days) in group B (p = 0.72). The number of AI’s until conception was 1 
(1/2) in group A compared to 1 (1/2) in group B (p = 0.59). Days open were 89 days (65/128 days) in group A 
compared to 96 days (71/120 days) in group B (p = 0.57) (Table 1). In group A, 1 cow was culled for fertility 
reasons compared to 4 cows in group B. There was no significant difference between the groups (p = 0.21). In 
group A, 6 cows were culled for other reasons compared to 7 in group B (p = 0.91). 
4. Discussion 
Public awareness of the prudent use of antibiotics in the dairy and food industry is steadily improving and the 
demand for alternative therapies is increasing [35]. 
The Swiss government is developing a concept called StAR (strategies against antimicrobial resistances). Our 
study aimed to use a phytotherapeutic drug (RN) to complement antibiotic therapy and after positive evaluation, 
to replace antibiotics in a follow-up study. Unfortunately, there was no significant difference as to number of 
treatments and as to fertility variables evaluated between the groups. Can we, therefore, deduce that RN did not 
exert a positive influence? Almost 100 farmers participated in the study; not all of them were convinced of the 
potential benefit of RN. The personal feedback from farmers which had already used alternative medicine was 
that RN had a positive effect on cows with RFM, whereas sceptical owners did not see an advantage in using a 
phytotherapeutic drug. Socioeconomic factors influence the way in which farmers use antimicrobials [36] and 
this may also hold true for administering phytotherapeutic substances. The aim of reducing the amount of anti-
biotics used in farm animal medicine and using alternative medicine instead, requires time in order to raise 
awareness. Although this work did not demonstrate a benefit of using RN, its strength was to show the farmers a 
different way of treating animals. A follow-up study will focus on farmers’ willing to reduce the amount of anti-
biotics in cows with RFM and using RN in their place, assuming that cows are not febrile and in good general 
condition. 
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